Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective study

International Journal of Cancer

Volumn 120, Issue 8, 2007, Pages 1782-1786

  Jacques Olivier, Bay ^a   Claude, Linassier ^b   Pierre, Biron ^c   Xavier, Durando ^a   Pierre, Verrelle ^a   Fabrice, Kwiatkowski ^a   Giovanni, Rosti ^d   Taner, Demirer ^e  

^a CENTRE JEAN PERRIN   (France)

^b CHU BRETONNEAU   (France)

^c CENTRE LÉON BÉRARD   (France)

^d SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^e ANKARA UNIVERSITY   (Turkey)

Author keywords

Autologous stem cell transplantation; High dose carmustine; High grade gliomas

Indexed keywords

CARMUSTINE; GRANULOCYTE COLONY STIMULATING FACTOR; MANNITOL; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; GLIOBLASTOMA; HUMAN; INTERSTITIAL PNEUMONIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUROLOGIC DISEASE; NEUROSURGERY; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION NECROSIS; SINGLE DRUG DOSE; SKIN MANIFESTATION; SURVIVAL TIME; THROMBOCYTOPENIA; THROMBOEMBOLISM; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 33947103643     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22305     Document Type: Article

References (23)

1. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-97.
2. Levin VA. Management of gliomas, medulloblastoma and CNS germ cell tumors. In: Cavalli F, Hansen HH, Kaye SB, eds. Textbook of medical oncology. London: Martin Dunitz, 1997309.
3. Prados MD, Russo C. Chemotherapy of brain tumors. Semin Surg Oncol 1998;14:88-95.
4. Surawicz TS, Davis F, Freels S, Laws ER, Jr, Menck HR. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 1998;40:151-60.
5. Forsyth PA, Roa WH. Primary central nervous system tumors in adults. Curr Treat Options Neurol 1999;1:377-94.
6. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011-18.
7. Stupp R, Mason WP, van den Bent MJ. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987-96.
8. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Caimcross G, Allgeier A, Lacombe D, Stupp R. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase IE randomized trial. J Clin Oncol 2006;24:2563-9.
9. Linassier C, Destrieux C, Benboubker L, Alcaraz L, Bergemer-Fouquet AM, Jan M, Calais G, Colombat P. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma]. Bull Cancer 2001;88:871-6 (in French).
10. Brem H, Mahaley MS, Jr, Vick NA, Black KL, Schold SC, Jr, Burger PC, Friedman AH. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 1991;74:441-6.
11. Mahaley MS, Jr, Whaley RA, Blue M, Bertsch L. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas. J Neurooncol 1986;3:297-314.
12. Recht L, Fram RJ, Strauss G, Fitzgerald TJ, Liepman M, Lew R, Kadish S. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU. A phase II trial. Am J Clin Oncol 1990;13:125-31.
13. Hildebrand J, Badjou R, Collard-Ronge E, Delforge A, Malarme M, Spiro T, Sztem B, Vandensteene A, Stryckmans PA. Treatment of brain giomas with high dose of CCNU and autologous bone marrow transplantation. Biomedicine 1980;32:71-5.
14. Hochberg FH, Parker LM, Takvorian T, Canellos GP, Zervas NT. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg 1981;54:455-60.
15. Takvorian T, Parker LM, Hochberg FH, Canellos GP. Autologous bone-marrow transplantation: host effects of high-dose BCNU. J Clin Oncol 1983;1:610-20.
16. Mortimer JE, Hewlett JS, Bay J, Livingston RB. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas. J Neurooncol 1983;1:269-73.
17. Phillips GL, Wolff SN, Fay JW, Herzig RH, Lazarus HM, Schold C, Herzig GP. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol 1986;4:639-45.
18. Johnson DB, Thompson JM, Corwin JA, Mosley KR, Smith MT, de los Reyes RA, Daly MB, Petty AM, Lamaster D, Pierson WP. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. J Clin Oncol 1987;5:783-9.
19. Biron P, Vial C, Chauvin F. Strategy including surgery, high dose BCNU followed by ABMT and radiotherapy in supratentorial high grade astrocytomas: a report of 98 patients. In: Dicke KA, Armitage JO, Dicke-Evinger MJ, eds. Autologous bone marrow transplantation: proceedings of the fifth international symposium. Omaha: University of Nebraska Medical Center, 1991, 637-645.
20. Linassier C, Benboubker L, Velut S, Calais G, Saudeau D, Jan M, Autret A, Berger C, Biron P, Colombat P. High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme. Bone Marrow Transplant 1996;18:569-S72.
21. Kwiatkowski F, Girard M, Hacene K, Berlie J. [Sem: a suitable statistical software adaptated for research in oncology]. Bull Cancer 2000; 87:715-21(in French).
22. Durando X, Lemaire JJ, Tortochaux J, Van-Praagh I, Kwiatkowski F, Vincent C, Bailly C, Verrelle P, Irthum B, Chazal J, Bay JO. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients. Bone Marrow Transplant 2003;31: 559-64.
23. Galanis E, Buckner J. Chemotherapy for high-grade gliomas. Br J Cancer 2000;82:1371-80.